SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001299933-11-001141
Filing Date
2011-04-19
Accepted
2011-04-19 17:01:19
Documents
3
Period of Report
2011-04-14
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 LIVE FILING htm_41386.htm 8-K 11839
2 EX-3.1 exhibit1.htm EX-3.1 4548
3 EX-3.2 exhibit2.htm EX-3.2 33067
  Complete submission text file 0001299933-11-001141.txt   50647
Mailing Address 4365 EXECUTIVE DRIVE, SUITE 300 SAN DIEGO CA 92121
Business Address 4365 EXECUTIVE DRIVE, SUITE 300 SAN DIEGO CA 92121 8584526600
LA JOLLA PHARMACEUTICAL CO (Filer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-24274 | Film No.: 11768622
SIC: 2836 Biological Products, (No Diagnostic Substances)